| 摘要 |
discloses is the use of whole blood cells without plasma, the plasma being separated from the whole blood cells by plasmapheresis, in the manufacture of a medicament for use in a method of treating cholesterol disorders, wherein the method comprises: administering a first treatment regime comprising two or more rounds of plasmapheresis to a patient having abnormal total cholesterol, abnormal LDL levels and/or abnormal HDL levels when measured before treatment, wherein the first treatment regime decreases LDL levels in patients having abnormal LDL levels and/or increases HDL levels in patients having abnormal HDL levels and, wherein each subsequent round of the first treatment regime maintains the new, lower total cholesterol level, lower LDL level, and/or higher HDL level. |
